A/Prof Spiros Fourlanos & Samantha Stuk

Experts / A/Prof Spiros Fourlanos & Samantha Stuk

A/Prof Spiros Fourlanos & Samantha Stuk

A/Prof Spiros Fourlanos is a consultant endocrinologist and the Director of the Royal Melbourne Hospital Department of Diabetes and Endocrinology and honorary Associate Clinical Professor with the University of Melbourne. He obtained his medical and PhD degrees at the University of Melbourne. His doctoral thesis was performed at the Walter & Eliza Hall Institute on ‘Latent Autoimmune Diabetes in Adults (LADA): New Clinical, Immunogenetic and Metabolic Perspectives’. He has authored over 100 peer-reviewed publications and is currently a stream lead in the University of Melbourne Australian Centre for Accelerating Diabetes Innovations collaborative. In conjunction with Professor Peter Colman he developed the BioGrid Diabetes Database which is now being used in multiple institutes in Australia for clinical care and benchmarking. He oversaw the Royal Melbourne Hospital becoming the first Australian hospital to have a complete automated networked blood glucose monitoring system. His clinical research interests include diabetes management in the hospital, medical device technologies for diabetes and adult-onset autoimmune diabetes. Spiros is currently a board member and honorary treasurer of the Australian Diabetes Society.

Samantha Stuk is an Accredited Practising Dietitian (APD) with 13 years of clinical experience across the public and private health sectors. In additional to her role as Principal Dietitian and Founder of The Nutrition Code, she is a senior dietitian within the Royal Melbourne Hospital endocrinology team. She has a special interest in diabetes (Type 1, Type 2 and Gestational), weight management and bariatric surgery. She is also skilled in heart disease and digestive health – including IBS and coeliac disease, and sports nutrition.

Maintaining muscle mass & nutritional status while losing weight on GLP-1RAs

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

Maintaining muscle mass & nutritional status while losing weight on GLP-1RAs

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

By A/Prof Spiros Fourlanos & Samantha Stuk

Podcasts

Diabetes and metabolism